McGraw Hill's Q3 FY2026 10-Q (quarter ended Dec 31, 2025) tells two stories running in opposite directions. The Higher Education digital transformation is working—revenue up 24% quarter-over-quarter to $225M, Adjusted EBITDA up 33% to $108M, 110% net dollar retention holding steady. Meanwhile K-12 collapsed 15% sequentially to $128M as state adoption cycles bottomed, and the company disclosed multi-state False Claims Act litigation that could metastasize across additional states with treble damages exposure. The CEO departed Feb 9 with no stated reason beyond "retirement" at a stock price 27% below the July 2025 IPO. Debt was $2.68B against a $2.4B market cap as of filing date, though the company aggressively deleveraged $596M in nine months using IPO proceeds.

What's actually happening

Higher Education is crushing it. Q3 revenue of $225M was up from $182M prior year quarter (+24% YoY) and $182M in Q2 FY2026 (+24% QoQ). Nine-month revenue hit $621M vs $528M prior year (+17.4%). The Inclusive Access subscription model—where institutions bundle digital content into tuition—is accelerating adoption. Digital revenue in HE reached $203M vs $163M prior year quarter. Re-occurring revenue (subscriptions) is now 71% of total company revenue, up from 66% last year. NDR at 110% means existing HE customers are expanding spend 10% annually through enrollment growth, price increases, and upselling. Q3 HE Adjusted EBITDA of $108M was 48% of segment revenue.

K-12 is in a known cyclical trough. Q3 revenue was $128M, down from $150M in Q3 last year and $543M in Q2 (the state adoption peak quarter). This isn't new information—K-12 is a lumpy state adoption-driven business. Texas and California drive the largest cycles, and FY2026 is an off-year. Nine-month K-12 revenue was $758M vs $830M prior year (-8.6%), entirely explained by adoption timing. K-12 Adjusted EBITDA for Q3 was $10M vs $26M prior year, compressed by lower revenue while fixed costs remained.

The litigation disclosure is the most material new information. On August 12, 2025, Florida filed a False Claims Act complaint alleging McGraw Hill overcharged school districts by not extending most-favored-nation pricing (charging some districts full price while offering same materials at lower prices or free to others). The complaint seeks treble damages, civil penalties, and attorneys' fees. A qui tam relator (whistleblower) filed the sealed complaint in May 2022; Florida intervened in August 2025 after a three-year investigation. McGraw Hill filed a Motion to Dismiss on October 13, 2025. Oral argument is scheduled for mid-February 2026 in Tallahassee.

On December 3, 2025, Illinois unsealed a second qui tam complaint filed by the same relator in July 2025, making similar claims. Illinois declined to intervene. The relator is executing a state-by-state strategy. McGraw Hill's 10-Q includes this sentence: "Given that other states have most favored nations pricing and mandatory free materials requirements for instructional materials, the Company believes it is possible that the Relator has filed under seal similar qui tam complaints in additional states" (emphasis added). Legal teams don't volunteer this language unless they think it's a real possibility.

CEO transition at the trough. Simon Allen announced retirement on December 30, 2025, effective February 9, 2026. Philip Moyer was appointed successor on January 2, 2026 and added to the Board. Allen remains Board Chair. The 10-Q states no disagreements or specific reason beyond "retirement." Allen is 63 (not unreasonable retirement age), but the timing is notable—stock at $12.34 vs $17 IPO seven months prior, down 27%, during litigation escalation and K-12 trough. Moyer received an $8M RSU grant plus $1.5M stock purchase opportunity at fair market value as of grant date.

Balance sheet: aggressively deleveraging but still heavy. Total debt declined from $3.28B (March 2025) to $2.68B (December 2025), a $596M reduction in nine months. The company used $386M of IPO proceeds and $200M cash in Q3 alone. Interest expense fell 29.5% year-to-date to $162M vs $230M prior year. September 2025 amendment reduced term loan margin by 50bps to SOFR+2.75%. Remaining debt: $564M term loan (2031 maturity), $828M 5.75% notes (2028), $639M 8% notes (2029), $650M 7.375% notes (2031). Cash was $514M with $450M undrawn revolvers. All covenants in compliance.

Market cap as of Feb 11 filing was ≈$2.4B (191M shares × $12.34). Debt exceeds equity. This makes the equity a levered call option on K-12 recovery + litigation resolution. High beta to both.

What the numbers mean

Segment performance (Q3 FY2026):

Nine-month totals:

• Total revenue: $1.64B (+0.7% YoY)
• Total Adj EBITDA: $614M (+3.1% YoY)
• Net income: $86M vs $71M prior year (+21%)
• Interest expense: $162M vs $230M prior year (-29.5%)

Re-occurring vs transactional revenue (Q3):

• Re-occurring: $357M (82% of total, up from 75% prior year)
• Transactional: $77M (18% of total, down from 25%)

The shift toward recurring revenue reduces volatility but doesn't eliminate K-12 cyclicality—K-12 digital subscriptions still layer on top of multi-year state adoption contracts.

Bear case you can't ignore

Treble damages math is ugly. Florida is the 3rd largest K-12 textbook market (≈$200M+ annual spend). If MH's Florida share is ≈25-30% (≈$50-60M annually over multiple years), and the state proves overcharges of 10-20% on affected contracts, base damages could be $10-20M. Treble damages = $30-60M for Florida alone. If the relator filed in 10-15 additional states (Texas, California, Illinois already disclosed, plus others with MFN clauses), and even half proceed, you're looking at $200-500M total exposure. Civil penalties and attorneys' fees add to this.

The company's own language—"it is possible that the Relator has filed under seal similar qui tam complaints in additional states"—is a soft admission this could be bigger than the two disclosed cases. Qui tam complaints remain sealed until the state decides whether to intervene, which can take 2-3 years. The Florida case was filed in May 2022 and unsealed August 2025 (3+ years). If the relator filed in other states in 2023-2024, those could unseal through 2026-2027.

The Motion to Dismiss hearing in mid-February 2026 is the near-term catalyst. If Florida's motion succeeds, the case gets materially weaker (though Illinois and potential other states remain). If it fails, expect the stock to reprice lower as the market models broader multi-state exposure.

Debt/equity >1 amplifies downside. With $2.68B debt and $2.4B market cap, equity holders are junior to $2.68B of claims. If litigation accelerates and earnings compress (legal costs + potential settlements), the equity could get deeply impaired. The 8% notes due 2029 and 7.375% notes due 2031 are expensive debt for a company trading at distressed-like multiples.

CEO departure during litigation escalation. Allen announced retirement Dec 30, weeks after the Illinois complaint unsealed Dec 3. Could be coincidental—he's 63, stayed on as Board Chair, and had been CEO since before the IPO process began. But "retirement" during rising litigation risk, stock down 27% from IPO, and no disclosed reason creates uncertainty. New CEO Moyer is being paid to clean up ($8M RSU grant is meaningful retention).

K-12 recovery is not guaranteed to be sharp. Even if FY2027 is a bigger adoption year (California, Texas on-cycle), state budgets are constrained, and the shift to digital reduces unit economics on legacy print products. The -8.6% YoY nine-month K-12 revenue decline is worse than pure adoption timing would suggest—some secular erosion is baked in.

Bull case if you're aggressive

HE growth is real and under-monetized. 110% NDR, 24% revenue growth, 48% EBITDA margins, and Inclusive Access adoption accelerating. This is a SaaS-like business trapped inside an education publisher multiple. If HE sustains $225M quarterly run-rate ($900M annualized) at 48% EBITDA margin, that's $432M EBITDA from HE alone. The market is pricing MH like a melting legacy publisher, not a company with a $900M high-margin digital subscription business.

Insiders bought at $15-16 in July-November 2025. Directors and executives purchased $1M+ of stock at prices 20-30% above current levels. Director Reinemund bought $236K at ≈$15 in November 2025. CFO, officers, directors all buying in the IPO aftermath. They know the litigation risk better than the market and still bought.

Street consensus at $20.83 (+69% upside) with 12 Buy/Hold, 0 Sells. Goldman at $22, Morgan Stanley at $21, BTIG at $22, BMO at $21. Only UBS is Neutral at $16. The consensus view is the market overreacted to K-12 cyclicality and litigation risk, and HE digital growth offsets both.

Q2 FY2026 EPS beat by 298% ($1.40 actual vs $0.35 estimate). This suggests the market systematically underestimates earnings power when HE is strong and K-12 is weak. If Q3 beats similarly (est $0.09), it would validate the bull case that operational execution is intact despite the noise.

Litigation may settle or dismiss. McGraw Hill's defense is that MFN clauses don't apply the way Florida alleges, and that pricing variations reflect legitimate differences in contract terms, volumes, and service levels. If the Motion to Dismiss succeeds in Florida, the entire multi-state thesis weakens (Illinois didn't intervene, which is a tell—state prosecutors review these and often pass if the case is weak). Settlement could be a manageable one-time charge rather than existential treble damages.

Deleveraging velocity is impressive. $596M debt reduction in 9 months, $200M in Q3 alone, interest expense down 30%. At this pace, they could bring debt below $2B by end of FY2026, improving the debt/equity ratio and reducing interest drag. Free cash flow in nine months was $375M from operations minus $187M capex = $188M, plus asset sales. The balance sheet is improving faster than the market is pricing.

RSI 22, down 22% in one month, 15% short interest. Oversold technicals + high short interest + earnings today (Feb 11) = potential for a violent short squeeze if Q3 beats and management delivers constructive commentary on litigation and K-12 outlook.

What I don't know

Why did Allen really retire now? The timing—December 30, 2025, seven months post-IPO, stock down 27%, litigation escalating—raises questions. He's 63 (reasonable retirement age) and staying as Board Chair (suggests no blowup), but CEOs don't usually retire during the first year post-IPO unless there's a reason. Is this a governance refresh to bring in a CEO better suited for the digital transition? Or is there something about litigation exposure or K-12 outlook that made him want to step back? The 10-Q discloses "no disagreements," but that's a low bar.

How many other states have sealed qui tam complaints? The company's explicit warning that "it is possible that the Relator has filed under seal similar qui tam complaints in additional states" is the most important sentence in the filing. Qui tam relators often file in multiple jurisdictions simultaneously and wait 2-3 years for state review. Florida took 3+ years from filing (May 2022) to unsealing (August 2025). If the relator filed in Texas, California, New York, and others in 2023-2024, those could unseal through 2026-2027. This is an information asymmetry the market can't price. The relator and state AGs know; McGraw Hill might not (sealed complaints aren't disclosed to defendants). Investors definitely don't.

What's the real liability number? Treble damages on overcharges across 10-15 states could be $200-500M, but that assumes (a) similar patterns in other states, (b) states intervene or relator wins on their own, (c) McGraw Hill loses on the merits. If the Motion to Dismiss succeeds in Florida and reveals a fundamental legal flaw in the theory, the risk collapses. If it fails and discovery reveals systematic MFN violations, the risk explodes. The mid-February 2026 oral argument is the catalyst.

Can K-12 return to growth or is this secular decline? Nine-month K-12 revenue down 8.6% YoY is worse than pure cyclicality. Part of this is adoption timing (FY2026 is off-cycle), but part could be secular shift to digital (lower price points, faster refresh cycles, less print revenue). If K-12 structurally earns $800-900M annually (vs $1.1B+ in peak years), then the company's $1.64B total revenue is the new steady-state, not a trough. That changes the valuation math.

What's in the Q3 earnings release today (Feb 11)? The 10-Q is backward-looking (Dec 31 quarter). Earnings call commentary on (a) litigation strategy, (b) K-12 pipeline for FY2027, (c) HE momentum, and (d) management confidence in guidance will move the stock more than the 10-Q numbers. If they beat the $0.09 estimate again (like Q2's 298% beat) and sound confident, RSI 22 + 15% short interest = covering rally. If they sound cautious on litigation or K-12, the path to $10 is open.

Verdict: Asymmetric but unquantifiable

This is a doorway state position—two coherent patterns fit the data, genuinely can't tell which yet.

Bull pattern (60% probability): HE digital business worth $3-4B alone (SaaS-like, 48% margins, 110% NDR, $900M revenue run-rate), K-12 recovers to $1B+ in FY2027 on-cycle, litigation settles for manageable $50-100M, deleveraging continues, stock re-rates to $18-22 (street consensus). Equity is call option on K-12 normalization + litigation resolution, and at $12.34 the option is cheap.

Bear pattern (40% probability): Multi-state litigation expands (5-10 additional states unseal in 2026), total exposure $300-500M, K-12 is structurally impaired (secular decline to $800M steady-state), debt burden + legal costs compress equity value, stock trades to $8-10 as market prices existential risk. CEO departure was a signal, not noise.

The catalyst that collapses the wavefunction: Florida Motion to Dismiss hearing mid-February 2026. If dismissed, bull pattern strengthens materially (though Illinois and potential other states remain). If denied, bear pattern strengthens and additional sealed complaints become higher probability.

Sizing implication: Not a core position. This is a 1-2% "lottery ticket" for asymmetric upside if litigation resolves favorably and K-12 recovers, sized to survive the bear case (stock to $8 = -35% loss, tolerable at 1-2% position size). Do NOT size this as a fundamental compounder—the debt/equity ratio and litigation cloud make it a binary bet, not a hold-forever SaaS story.

Edge is in the timing: Retail can act faster than institutions on the Feb 11 earnings call + mid-Feb Motion to Dismiss outcome. If both break bullish (earnings beat + motion granted or favorable signals), the gap from $12 to street consensus $21 happens fast. Institutions take 90-120 days to accumulate. But if either breaks bearish, the reflexive selloff is also fast and brutal given 15% short interest and weak hands post-IPO.

Final take: The worker was wrong to call this "not urgent." The convergence of CEO departure, deeply oversold technicals (RSI 22), massive street disconnect ($12 vs $21 consensus), earnings today, Motion to Dismiss in days, and call-option-like equity structure makes this worth watching closely. But the reviewer was also wrong to call it a "slam dunk asymmetric setup"—the multi-state litigation risk is real, unquantifiable, and could be existential if the Florida motion fails and 10+ other states unsealed with similar claims. This is a trade, not an investment. Know your catalyst timeline (Feb 11 earnings, mid-Feb motion, potential additional state unseals in 2026) and size for survival of the bear case.